Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4-methylbenzyl 3-fluoro-4-((pyrimidin-2-ylamino)methyl)piperidine-1-carboxylate
2. Mk-0657
1. Mk-0657
2. 808732-98-1
3. Cerc-301
4. Rislenemdaz [usan]
5. Rislenemdaz, (-)-
6. Mk-0657, (-)-
7. 1dy7m91wq1
8. 5ham167s5t
9. 808733-05-3
10. Mk-0657, (+/-)-
11. 808732-98-1 (free Base)
12. 4-methylbenzyl (3s,4r)-3-fluoro-4-((pyrimidin-2-ylamino)methyl)piperidine-1-carboxylate
13. Rislenemdaz (usan)
14. Cis-4-methylbenzyl 3-fluoro-4-((pyrimidin-2-ylamino)methyl)piperidine-1-carboxylate
15. 1-piperidinecarboxylic Acid, 3-fluoro-4-((2-pyrimidinylamino)methyl)-, (4-methylphenyl)methyl Ester, (3r,4s)-rel-
16. 1-piperidinecarboxylic Acid, 3-fluoro-4-((2-pyrimidinylamino)methyl)-, (4-methylphenyl)methyl Ester, (3s,4r)-
17. Chembl2036513
18. 1-piperidinecarboxylic Acid, 3-fluoro-4-[(2-pyrimidinylamino)methyl]-, (4-methylphenyl)methyl Ester, (3r,4s)-rel-
19. Unii-1dy7m91wq1
20. Unii-5ham167s5t
21. Rislenemdaz [inn]
22. Rislenemdaz [who-dd]
23. Schembl4469674
24. Chembl2068839
25. Rislenemdaz, (+/-)-
26. Dtxsid801031864
27. Zinc6716889
28. Bdbm50385169
29. Mfcd14635204
30. Akos037643749
31. Cs-7798
32. Db12063
33. Hy-106441a
34. As-35130
35. D11340
36. Q18205913
37. Racemic Cis-4-methylbenzyl 3-fluoro-4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate
38. (-)-(3s,4r)-4-methylbenzyl 3-fluoro-4-((pyrimidin-2-ylamino)methyl)piperidine-1-carboxylate
39. (-)-(3s,4r)-4-methylbenzyl-3-flouro-4-((pyrimidin-2-ylamino)methyl)piperidine-1-carboxylate
40. (4-methylphenyl)methyl (3s,4r)-3-fluoro-4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate
41. 1221592-28-4
| Molecular Weight | 358.4 g/mol |
|---|---|
| Molecular Formula | C19H23FN4O2 |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 358.18050415 g/mol |
| Monoisotopic Mass | 358.18050415 g/mol |
| Topological Polar Surface Area | 67.4 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 439 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
58
PharmaCompass offers a list of Rislenemdaz API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rislenemdaz manufacturer or Rislenemdaz supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rislenemdaz manufacturer or Rislenemdaz supplier.
PharmaCompass also assists you with knowing the Rislenemdaz API Price utilized in the formulation of products. Rislenemdaz API Price is not always fixed or binding as the Rislenemdaz Price is obtained through a variety of data sources. The Rislenemdaz Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Rislenemdaz manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rislenemdaz, including repackagers and relabelers. The FDA regulates Rislenemdaz manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rislenemdaz API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Rislenemdaz supplier is an individual or a company that provides Rislenemdaz active pharmaceutical ingredient (API) or Rislenemdaz finished formulations upon request. The Rislenemdaz suppliers may include Rislenemdaz API manufacturers, exporters, distributors and traders.
Rislenemdaz Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rislenemdaz GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rislenemdaz GMP manufacturer or Rislenemdaz GMP API supplier for your needs.
A Rislenemdaz CoA (Certificate of Analysis) is a formal document that attests to Rislenemdaz's compliance with Rislenemdaz specifications and serves as a tool for batch-level quality control.
Rislenemdaz CoA mostly includes findings from lab analyses of a specific batch. For each Rislenemdaz CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rislenemdaz may be tested according to a variety of international standards, such as European Pharmacopoeia (Rislenemdaz EP), Rislenemdaz JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rislenemdaz USP).
